Recombinant Therapeutic Antibodies and Proteins Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Recombinant Therapeutic Antibodies and Proteins Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Therapeutic Antibodies and Proteins Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Therapeutic Antibodies and Proteins Overall Market Size
2.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size: 2021 VS 2027
2.2 Global Recombinant Therapeutic Antibodies and Proteins Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Therapeutic Antibodies and Proteins Players in Global Market
3.2 Top Global Recombinant Therapeutic Antibodies and Proteins Companies Ranked by Revenue
3.3 Global Recombinant Therapeutic Antibodies and Proteins Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Therapeutic Antibodies and Proteins Companies in Global Market, by Revenue in 2020
3.5 Global Companies Recombinant Therapeutic Antibodies and Proteins Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Therapeutic Antibodies and Proteins Players in Global Market
3.6.1 List of Global Tier 1 Recombinant Therapeutic Antibodies and Proteins Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant Therapeutic Antibodies and Proteins Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Therapeutic Antibodies and Proteins Market Size Markets, 2021 & 2027
4.1.2 Plasma Protein
4.1.3 Fusion Proteins
4.1.4 Monoclonal Antibodies
4.1.5 Hormones
4.1.6 Enzyme
4.1.7 Coagulation Factors
4.1.8 Others
4.2 By Type - Global Recombinant Therapeutic Antibodies and Proteins Revenue & Forecasts
4.2.1 By Type - Global Recombinant Therapeutic Antibodies and Proteins Revenue, 2016-2021
4.2.2 By Type - Global Recombinant Therapeutic Antibodies and Proteins Revenue, 2022-2027
4.2.3 By Type - Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Therapeutic Antibodies and Proteins Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Hematology
5.1.4 Immunology
5.1.5 Endocrinology
5.1.6 Infectious Disease
5.1.7 Cardiovascular Disease
5.1.8 Others
5.2 By Application - Global Recombinant Therapeutic Antibodies and Proteins Revenue & Forecasts
5.2.1 By Application - Global Recombinant Therapeutic Antibodies and Proteins Revenue, 2016-2021
5.2.2 By Application - Global Recombinant Therapeutic Antibodies and Proteins Revenue, 2022-2027
5.2.3 By Application - Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Recombinant Therapeutic Antibodies and Proteins Market Size, 2021 & 2027
6.2 By Region - Global Recombinant Therapeutic Antibodies and Proteins Revenue & Forecasts
6.2.1 By Region - Global Recombinant Therapeutic Antibodies and Proteins Revenue, 2016-2021
6.2.2 By Region - Global Recombinant Therapeutic Antibodies and Proteins Revenue, 2022-2027
6.2.3 By Region - Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Recombinant Therapeutic Antibodies and Proteins Revenue, 2016-2027
6.3.2 US Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.3.3 Canada Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.3.4 Mexico Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Recombinant Therapeutic Antibodies and Proteins Revenue, 2016-2027
6.4.2 Germany Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.4.3 France Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.4.4 U.K. Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.4.5 Italy Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.4.6 Russia Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.4.7 Nordic Countries Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.4.8 Benelux Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Recombinant Therapeutic Antibodies and Proteins Revenue, 2016-2027
6.5.2 China Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.5.3 Japan Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.5.4 South Korea Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.5.5 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.5.6 India Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Recombinant Therapeutic Antibodies and Proteins Revenue, 2016-2027
6.6.2 Brazil Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.6.3 Argentina Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Revenue, 2016-2027
6.7.2 Turkey Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.7.3 Israel Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.7.4 Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
6.7.5 UAE Recombinant Therapeutic Antibodies and Proteins Market Size, 2016-2027
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.1.4 Abbott Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.1.5 Abbott Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.2.4 Amgen Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.2.5 Amgen Key News
7.3 Biogen
7.3.1 Biogen Corporate Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.3.4 Biogen Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.3.5 Biogen Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.4.4 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.4.5 Eli Lilly Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.5.4 Roche Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.5.5 Roche Key News
7.6 Johnson and Johnson
7.6.1 Johnson and Johnson Corporate Summary
7.6.2 Johnson and Johnson Business Overview
7.6.3 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.6.4 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.6.5 Johnson and Johnson Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.4.4 Merck Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.7.5 Merck Key News
7.8 Novo Nordisk
7.8.1 Novo Nordisk Corporate Summary
7.8.2 Novo Nordisk Business Overview
7.8.3 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.8.4 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.8.5 Novo Nordisk Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.9.4 Pfizer Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.9.5 Pfizer Key News
7.10 Sanofi
7.10.1 Sanofi Corporate Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Recombinant Therapeutic Antibodies and Proteins Major Product Offerings
7.10.4 Sanofi Recombinant Therapeutic Antibodies and Proteins Revenue in Global (2016-2021)
7.10.5 Sanofi Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Recombinant Therapeutic Antibodies and Proteins Market Opportunities & Trends in Global Market
Table 2. Recombinant Therapeutic Antibodies and Proteins Market Drivers in Global Market
Table 3. Recombinant Therapeutic Antibodies and Proteins Market Restraints in Global Market
Table 4. Key Players of Recombinant Therapeutic Antibodies and Proteins in Global Market
Table 5. Top Recombinant Therapeutic Antibodies and Proteins Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Recombinant Therapeutic Antibodies and Proteins Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Companies, 2016-2021
Table 8. Global Companies Recombinant Therapeutic Antibodies and Proteins Product Type
Table 9. List of Global Tier 1 Recombinant Therapeutic Antibodies and Proteins Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Therapeutic Antibodies and Proteins Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type